Brief: FDA Says American Regent Recalled One Lot Of Papaverine Hydrochloride Injection
27/07/2026 16:39
BRIEF-FDA Says American Regent Recalled One Lot Of Papaverine Hydrochloride Injection July 27 (Reuters) - US FDA:
US FDA - AMERICAN REGENT RECALLS ONE LOT OF PAPAVERINE HYDROCHLORIDE INJECTION DUE TO PARTICULATE MATTER
US FDA - RECALL DUE TO GLASS AND/OR PARAFORMALDEHYDE PARTICULATE IN PAPAVERINE HYDROCHLORIDE INJECTION
US FDA - NO ADVERSE EVENTS REPORTED TO DATE FOR RECALLED PAPAVERINE HYDROCHLORIDE INJECTION
((Reuters.Briefs@thomsonreuters.com;))